BXR Group
BXR Group is a private equity and venture capital firm based in Budapest, Hungary, with additional offices in Prague and London. The firm focuses on direct and fund investments across a diverse range of sectors, including mining, transport, infrastructure, real estate, agriculture, financial services, media, energy, chemicals, healthcare, telecommunications, and retail. BXR Group aims to acquire majority control or significant minority stakes in its portfolio companies, investing between €10 million and €250 million in various stages of business maturity. Its investment strategy encompasses different regions, including Western Europe, the Americas, Asia, and Australasia. BXR Partners, a subsidiary of BXR Group, provides investment advisory services, assisting in identifying opportunities and executing acquisitions while offering strategic guidance to enhance the performance of portfolio companies.
We use science and data in our precision insurance solution, Rideshur to accurately price any road segment in real-time.
We started with a simple idea: collect enough data from cars and figure out a way to monetise the asset. It turns out that insurance was the problem worth solving, but Humn was born digital-native.
Data first, then insurance, and this gives us a tremendous advantage over incumbents and other players.
What this means for us is a relentless drive to bring together the best talents in streaming data and machine learning with experienced operations and insurance folks to build a unique full-stack platform. We believe in this mission. We're all in. Are you with us?
We use science and data in our precision insurance solution, Rideshur to accurately price any road segment in real-time.
We started with a simple idea: collect enough data from cars and figure out a way to monetise the asset. It turns out that insurance was the problem worth solving, but Humn was born digital-native.
Data first, then insurance, and this gives us a tremendous advantage over incumbents and other players.
What this means for us is a relentless drive to bring together the best talents in streaming data and machine learning with experienced operations and insurance folks to build a unique full-stack platform. We believe in this mission. We're all in. Are you with us?
Treos Bio is a clinical-stage biotechnology company focused on developing precision cancer immunotherapies tailored to the genetic profiles of patients. Founded in 2013 and based in San Francisco, the company utilizes proprietary technology to predict individual responses to cancer immunotherapies. Treos Bio offers several products, including PEPI, a test that analyzes genetic data from blood or saliva samples to forecast an individual's immune response to specific antigens. The company also develops PolyPEPI immunotherapy vaccines targeting various cancers such as melanoma, lung cancer, and breast cancer, alongside the PolyPEPI CDx companion diagnostic test, which assesses the effectiveness of treatments for individual patients. Additionally, Treos Bio provides a melanoma screening test to identify individuals at high risk of developing the disease based on genetic information. Through the integration of computational data science and proprietary biomarkers, Treos Bio aims to personalize cancer treatment with targeted vaccines and diagnostic tools.
Hoyo Hoyo Agribusiness
Venture Round in 2016
Hoyo Hoyo Agribusiness is a oilseed producers in the country, Hoyo Hoyo restores and develops a large scale agricultural concession.
Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Isfiya, Israel, focused on developing an innovative capsule-based system, C-Scan, for colorectal cancer screening. This system employs low-dose X-rays to detect polyps and masses, aiming to provide a non-invasive and preparation-free alternative to traditional colonoscopies. The C-Scan system includes three components: the C-Scan Cap, an ingestible capsule that collects and transmits structural information; the C-Scan Track, a biocompatible device worn by the patient for tracking and data recording; and C-Scan View, software that processes and visualizes the collected clinical data in 3D. Founded in 2004, Check-Cap aims to market its products in the United States, Europe, Israel, and Japan, targeting a significant need for accurate and accessible colorectal cancer screening solutions.
Malawi Mangoes is a fruit producer in Malawi developing its own agricultural operations and smallholder sourcing schemes as well as pulp processing and distribution capacity to target the growing global demand for tropical fruit purées. BXR Group holds a significant minority stake.
Private Equity Round in 2011
Marex Spectron is a world leading commodity broker offering unrivalled breadth of commodity market coverage across Metals, Agricultural and Energy products, with extensive services, diversified client base, platform scalability, and leading proprietary technology, data and analytics offerings. While other competitors might match their offering in one specific commodity category, they are unique in being top ranked across Metals, Energy and Agricultural products.
Private Equity Round in 2010
Central European Petroleum is a petroleum exploration and production company that focuses on the European Union.
Private Equity Round in 2009
ETX Capital is a leading company in the CFD and spread betting market, offering a broad range of services to retail, high net worth and institutional customers through its powerful online trading platform. ETX Capital provides investors with multi asset and multi market derivate dealing capability through CFDs and spread betting products. Award wins include "Best Futures & Options Broker" (Shares Awards, 2011) and "Value for Money" (Investment Trends July, 2011).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.